# Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients

> **NCT01002573** · PHASE3 · COMPLETED · sponsor: **Cumberland Pharmaceuticals** · enrollment: 118 (actual)

## Conditions studied

- Fever

## Interventions

- **DRUG:** ibuprofen
- **DRUG:** acetaminophen

## Key facts

- **NCT ID:** NCT01002573
- **Lead sponsor:** Cumberland Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2016-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002573, "Safety, Efficacy, and Pharmacokinetic Study of Intravenous Ibuprofen in Pediatric Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01002573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*